APVO vs COST · $9.9M cap vs P/E 55, rev $275.24B
Aptevo Therapeutics Inc (APVO) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
APVO does not have a complete income-statement cache yet.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
APVO currently screens at market cap $9.9M. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the APVO and COST stock pages for the full models.
Not investment advice.